Literature DB >> 26288490

Distribution of hepatitis B virus genotype and cancer predicting precore and basal core promoter mutations.

A K Agarwal1, Sourav Sen2, Debabrata Banerjee3, Rakesh Srivastava4, A K Praharaj5.   

Abstract

BACKGROUND: Chronic hepatitis B (CHB) infection which is associated with an increased risk of developing liver disease including cirrhosis and hepatocellular carcinoma. Viral factors that may increase the risk for HCC development include HBV DNA level, genotypes, and naturally occurring mutations such as hepatitis B virus precore (PC) (G1896A) and basal core promoter (BCP) A1762T/G1764A double mutations. HBV genotypes and subgenotypes can significantly influence HBeAg seroconversion rates, viremia levels, mutational patterns that could significantly influence the heterogeneity in clinical manifestations and even response to antiviral therapy.
METHOD: 94 CHB infected individuals with detectable serum HBV DNA levels were studied. HBsAg, HBeAg, anti-HBc IgM antibody estimations were done by ELISA. HBV DNA estimation was done. The HBV genotypes were determined by TSP-PCR and 10 samples randomly selected for DNA sequencing. PC and BCP mutations were determined by DNA sequence analysis of core region. RESULT: Of 94 study participant samples with detectable serum HBV DNA levels, 75 were successfully genotyped and sequenced for BCP/PC region. 30/75 (40%) harbored PC and BCP mutations. The total Double mutations of BCP at A1762T/G1764A nucleotide positions, and PC mutation at G1896A nucleotide position were seen in 29.3% and 21.3%, respectively. All 75 isolates were subtype D using TSP-PCR. However, by sequencing 2/10 were subtype A, while 8 were subtype D.
CONCLUSION: Our study reinforces that D is the predominant genotype in Indian population. It reveals that Indian CHB subjects have increased prevalence of BCP & PC mutations, which possibly may lead to development of HCC.

Entities:  

Keywords:  Basal core promoter mutations; Chronic hepatitis B; Genotype; Pre core mutations

Year:  2015        PMID: 26288490      PMCID: PMC4534539          DOI: 10.1016/j.mjafi.2015.04.003

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  21 in total

1.  Genetic diversity of hepatitis B virus as an important factor associated with differences in clinical outcomes.

Authors:  Yasuhito Tanaka; Masashi Mizokami
Journal:  J Infect Dis       Date:  2006-11-21       Impact factor: 5.226

2.  Clinical relevance and public health significance of hepatitis B virus genomic variations.

Authors:  Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

3.  Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.

Authors:  Ranjit Chauhan; Syed N Kazim; Jayshree Bhattacharjee; Puja Sakhuja; Shiv K Sarin
Journal:  J Med Virol       Date:  2006-08       Impact factor: 2.327

Review 4.  The clinical implications of hepatitis B virus genotype: Recent advances.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

5.  The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B.

Authors:  Brian J McMahon
Journal:  Hepatol Int       Date:  2008-11-26       Impact factor: 6.047

6.  Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India.

Authors:  Arup Banerjee; Fuat Kurbanov; Sibnarayan Datta; Partha Kumar Chandra; Yasuhito Tanaka; Masashi Mizokami; Runu Chakravarty
Journal:  J Med Virol       Date:  2006-09       Impact factor: 2.327

7.  Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India.

Authors:  Perumal Vivekanandan; Priya Abraham; Gopalan Sridharan; George Chandy; Dolly Daniel; Sukanya Raghuraman; Hubert Darius Daniel; Thenmozhi Subramaniam
Journal:  Clin Infect Dis       Date:  2004-04-09       Impact factor: 9.079

Review 8.  Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.

Authors:  V T T Nguyen; M G Law; G J Dore
Journal:  J Viral Hepat       Date:  2009-03-17       Impact factor: 3.728

9.  Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.

Authors:  Hwai-I Yang; Shiou-Hwei Yeh; Pei-Jer Chen; Uchenna H Iloeje; Chin-Lan Jen; Jun Su; Li-Yu Wang; Sheng-Nan Lu; San-Lin You; Ding-Shinn Chen; Yun-Fan Liaw; Chien-Jen Chen
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

Review 10.  An overview of molecular epidemiology of hepatitis B virus (HBV) in India.

Authors:  Sibnarayan Datta
Journal:  Virol J       Date:  2008-12-19       Impact factor: 4.099

View more
  3 in total

Review 1.  Current Scenario of Hepatitis B and Its Treatment in India.

Authors:  Gautam Ray
Journal:  J Clin Transl Hepatol       Date:  2017-07-08

2.  Hepatitis B virus precore G1896A mutation in chronic liver disease patients with HBeAg negative serology from North India.

Authors:  Abdul Malik; Deepak Kumar; Abdul Arif Khan; Azmat Ali Khan; Anis Ahmad Chaudhary; Syed Akhtar Husain; P Kar
Journal:  Saudi J Biol Sci       Date:  2016-05-10       Impact factor: 4.219

3.  Nucleotide Substitutions in Hepatitis B Viruses Derived from Chronic HBV Patients.

Authors:  Narjes Shokatpour; Maryam Vaezjalali; Graham R Foster; Shahnaz Sali
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-07-01       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.